Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Rapport Therapeutics, Inc.

NASDAQ: RAPP · Life Sciences · 15 alerts · CIK 2012593

Share price
$24.82Close, Nov 16
Market cap
$1.47B
Shares outstanding
59.28MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Rapport Therapeutics, Inc. filings on SEC EDGAR ↗

4:30 PM ET Form 4
Insider Selling

Rapport Therapeutics CEO Abraham Ceesay Sells $64.4K of Stock

Abraham Ceesay, CEO, sold 2,210 shares of Rapport Therapeutics, Inc. at $29.16 a share, worth $64.4K in total on Oct 21, 2026. Shares held after the trade: 450,035 (-0.5%).

Value
$64.4K
Shares
2,210
Price
$29.16
Role
CEO
Holding change
-0.5%
Trade date
Oct 21, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.